Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers

Pediatrics

Volumn 131, Issue 6, 2013, Pages

  Klein, Nicola P ^a   Bartlett, Joan ^a   Fireman, Bruce ^a   Rowhani Rahbar, Ali ^a   Baxter, Roger ^a  

^a KAISER PERMANENTE   (United States)

Author keywords

Acellular pertussis vaccine; Pertussis infection; Teenagers; Whole cell pertussis vaccine

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS WHOLE CELL PERTUSSIS VACCINE; PERTUSSIS VACCINE; UNCLASSIFIED DRUG;

ADOLESCENCE; ADOLESCENT; ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PERTUSSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; TREATMENT RESPONSE; VACCINATION;

ACELLULAR PERTUSSIS VACCINE; PERTUSSIS INFECTION; TEENAGERS; WHOLE CELL PERTUSSIS VACCINE;

ADOLESCENT; CALIFORNIA; CASE-CONTROL STUDIES; CHILD; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; PERTUSSIS VACCINE; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; UNITED STATES; WHOOPING COUGH;

EID: 84878704269     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2012-3836     Document Type: Article

References (28)

1. Cherry JD, Brunnel P, Golden G. Report of the Task Force on Pertussis and Pertussis Immunization. Pediatrics. 1988;81(suppl):933-984
2. Cody CL, Baraff LJ, Cherry JD, Marcy SM, Manclark CR. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics. 1981;68(5):650-660 (Pubitemid 11029708)
3. Matheson AJ, Goa KL. Diphtheria-tetanusacellular pertussis vaccine adsorbed (Triacelluvax; DTaP3-CB): a review of its use in the prevention of Bordetella pertussis infection. Paediatr Drugs. 2000;2(2):139-159 (Pubitemid 30167299)
4. Pertussis vaccination: acellular pertussis vaccine for the fourth and fifth doses of the DTP series update to supplementary ACIP statement. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1992;41 (RR-15):1-5
5. America Academy of Pediatrics Committee on Infectious Diseases. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. Pediatrics. 2006;117(3):965-978
6. Salmaso S, Mastrantonio P, Tozzi AE, et al Stage III Working Group. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience. Pediatrics. 2001;108(5). Available at: www.pediatrics.org/cgi/content/full/108/5/e81
7. Lugauer S, Heininger U, Cherry JD, Stehr K. Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccine. Eur J Pediatr. 2002;161(3):142-146 (Pubitemid 34169862)
8. Olin P, Gustafsson L, Barreto L, et al. Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine. Vaccine. 2003;21(17-18):2015-2021
9. Vickers D, Ross AG, Mainar-Jaime RC, Neudorf C, Shah S. Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children. CMAJ. 2006;175(10):1213-1217 (Pubitemid 44787097)
10. Cherry JD. The present and future control of pertussis. Clin Infect Dis. 2010;51(6):663-667
11. Sheridan SL, Ware RS, Grimwood K, Lambert SB. Number and order of whole cell pertussis vaccines in infancy and disease protection. JAMA. 2012;308(5):454-456
12. Farizo KM, Cochi SL, Zell ER, Brink EW, Wassilak SG, Patriarca PA. Epidemiological features of pertussis in the United States, 1980-1989. Clin Infect Dis. 1992;14(3):708-719
13. Güriş D, Strebel PM, Bardenheier B, et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis. 1999;28(6):1230-1237 (Pubitemid 29272795)
14. Klein NP, Bartlett J, Rowhani-Rahbar A, Fireman B, Baxter R. Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med. 2012;367 (11):1012-1019
15. Misegades LK, Winter K, Harriman K, et al. Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010. JAMA. 2012;308(20):2126-2132
16. Notes from the Field. Pertussis-California, January-June 2010. MMWR Morb Mortal Wkly Rep. 2010;59(26):817
17. Elliott MN, Fremont A, Morrison PA, Pantoja P, Lurie N. A new method for estimating race/ethnicity and associated disparities where administrative records lack self-reported race/ethnicity. Health Serv Res. 2008;43(5 pt 1):1722-1736
18. Armitage P. Tests for linear trends in proportions and frequencies. Biometrics. 1955; 11(3):375-386
19. Ausiello CM, Urbani F, la Sala A, Lande R, Cassone A. Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines. Infect Immun. 1997;65(6):2168-2174 (Pubitemid 27237293)
20. Mascart F, Hainaut M, Peltier A, Verscheure V, Levy J, Locht C. Modulation of the infant immune responses by the first pertussis vaccine administrations. Vaccine. 2007;25 (2):391-398 (Pubitemid 44873143)
21. Ryan M, Murphy G, Ryan E, et al. Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology. 1998;93(1):1-10 (Pubitemid 28133089)
22. Esposito S, Agliardi T, Giammanco A, et al. Long-term pertussis-specific immunity after primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine in comparison with that after natural infection. Infect Immun. 2001;69(7):4516-4520 (Pubitemid 32574452)
23. Ausiello CM, Lande R, Urbani F, et al. Cell-mediated immune responses in four-yearold children after primary immunization with acellular pertussis vaccines. Infect Immun. 1999;67(8):4064-4071 (Pubitemid 29357029)
24. Dirix V, Verscheure V, Goetghebuer T, et al. Cytokine and antibody profiles in 1-year-old children vaccinated with either acellular or whole-cell pertussis vaccine during infancy. Vaccine. 2009;27(43):6042-6047
25. Rieber N, Graf A, Hartl D, Urschel S, Belohradsky BH, Liese J. Acellular pertussis booster in adolescents induces Th1 and memory CD8+ T cell immune response. PLoS ONE. 2011;6(3):e17271
26. Hendrikx LH, Schure RM, Oztürk K, et al. Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary vaccinations in healthy and pertussis infected children. Vaccine. 2011;29 (40):6874-6880
27. Rieber N, Graf A, Belohradsky BH, et al. Differences of humoral and cellular immune response to an acellular pertussis booster in adolescents with a whole cell or acellular primary vaccination. Vaccine. 2008;26(52):6929-6935
28. Prelog M, Almanzar G, Rieber N, Ottensmeier B, Zlamy M, Liese J. Differences of IgG antibody avidity after an acellular pertussis (aP) booster in adolescents after a whole cell (wcP) or aP primary vaccination. Vaccine. 2013;31(2):387-393